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Abstract
Sub-Saharan Africa is endemic for Kaposi’s sarcoma-associated herpesvirus (KSHV) and there is
a high rate of early childhood infection; however, the transmission sources are not well
characterized. We examined household members as potential KSHV transmission sources to
young children in the KSHV-endemic country of Zambia. To this end, we enrolled and followed
Zambian households with at least one KSHV-seropositive child and collected longitudinal buccal
swab samples. KSHV burden was evaluated and K1 sequences from the children were determined
and analyzed for differences to K1 sequences from household members. The K1 sequences were
also analyzed for evolution over time. We generated K1 sequences from 31 individuals across 16
households. Nine households contained multiple KSHV-positive members, including at least one
child. In 6 of 9 households, the child had 100% sequence identity to all household members.
However, in two households the child and mother had distinct K1 sequences. In the remaining
household, the children were the only KSHV-infected individuals. Furthermore, we report that 1
of 18 individuals had K1 sequence variation within the timespan analyzed. In the present study,
we provide evidence that (1) early childhood KSHV transmission occurs from both within and
outside the household, (2) intra-household transmission can occur via non-maternal sources, (3)
viral shedding in the buccal cavity is highly variable, and (4) the dominant K1 sequence within an
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The present study is the first to describe a molecular analysis of Kaposi’s sarcoma-associated herpesvirus (KSHV) transmission to
children in a longitudinal cohort of KSHV-positive children and their entire households in Zambia—a country endemic for KSHV and
Kaposi’s sarcoma. Our results have important implications for the development of strategies to prevent KSHV transmission to young
children and reduce Kaposi’s sarcoma incidence in endemic areas.
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individual did not rapidly evolve over time. These results are important for developing KSHV
intervention strategies.
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INTRODUCTION
Kaposi’s sarcoma-associated herpesvirus (KSHV), or human herpesvirus-8 (HHV-8), is the
etiological agent of all forms of Kaposi’s sarcoma (KS), along with primary effusion
lymphoma and multicentric Castleman’s disease.1–5 Global seroprevalence of KSHV is
uneven; it is low in the United States and Western Europe, moderate in the Mediterranean,
and as high as 80% in sub-Saharan Africa.6–-9 Zambia is one such country in sub-Saharan
Africa stricken by high KSHV and KS prevalence, and with the onset of the HIV-1
epidemic, a drastic increase in KS cases was seen in both adults and children.10, 11 By 1992,
KS accounted for approximately 25% of all childhood cancers diagnosed in Lusaka, the
capitol of Zambia, making KS one of the most frequently diagnosed cancers.12
Since a KSHV vaccine is not likely to be available in the near future, elucidating the route
and people involved as sources of transmission is imperative for the development of
strategies to reduce KSHV spread and infection rates in endemic areas such as Zambia. Our
previous study established that early childhood infection by KSHV is common in Zambia:
approximately 40% of children were infected by four years of age.13 We and others have
also shown that KSHV DNA is frequently detectable in saliva, indicating salivary contact as
the major route of horizontal transmission to children in endemic regions.7, 14, 15
Nevertheless, the individuals involved as sources of KSHV transmission to children have yet
to be identified. Previous studies of KSHV transmission have primarily focused on mother-
to-child transmission, but salivary contact with children is not limited to the child’s mother.
Moreover, we have shown that KSHV incidence is similar in children born to KSHV-
positive and -negative mothers, suggesting that KSHV transmission can come from sources
other than the mother.13 Therefore, to develop adequate KSHV intervention strategies in
endemic areas, it is essential to evaluate the role of all personal contacts, including
household members, as potential viral transmission sources during early childhood.
Despite a high level of genomic conservation, KSHV contains a gene on the extreme left-
hand end of the genome, K1, that is highly variable.16 K1 is an 870-nucleotide gene that
encodes a signal transducing, cell surface glycoprotein important in transformation of
KSHV-infected and surrounding cells as well as induction of inflammatory proteins and
downregulation of the B-cell receptor.17 The majority of K1 sequence variation is
concentrated within two regions of the gene’s extracellular domain, variable region (VR) 1
and 2, which are 40- and 38-nucleotides respectively.16 Due to its high variability, K1 is
routinely used to classify KSHV into at least five different genotypes (A, B, C, D, and E),
and various sub-genotypes.16, 18
Using molecular analysis of K1, we examined a longitudinal cohort of KSHV-seropositive
children and all members of their households in the KSHV endemic country of Zambia—
making this study the first of its kind. Here, we provide evidence that transmission of KSHV
to children can occur from both within and outside the household and intra-household
transmission may occur via non-maternal sources. Furthermore, we report that
superinfection was not detected in any individuals, and the dominant K1 sequence in the
buccal cavity of an individual did not rapidly change over time. Additionally, we analyzed
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KSHV burden in the buccal cavity longitudinally and report that viral shedding is highly
variable within an individual over time. Our findings have important implications for the
development of strategies to prevent KSHV transmission to young children in endemic
regions.
METHODS
Study Population
In the present study, participants were recruited from various compounds within Lusaka
District, Zambia. We enrolled and followed all willing and eligible complete households (n
= 134, 455 individuals) during September 2004 to November 2009. Eligible complete
households were defined as family units in which (1) all related individuals who resided in
the same dwelling agreed to participate in the study and (2) there was at least one KSHV-
seropositive child under the age of four years (index child). Family units described in this
study will herein be denoted as “households.” Venous blood and buccal swab samples were
collected from each index child and mother every four months and from all other household
members once a year at the University Teaching Hospital (UTH) in Lusaka for up to four
years. KSHV serostatus was determined for each household member by monoclonal-
enhanced immunofluorescence assay, as previously described.19 Additionally, presence of
HIV-1 antibodies was determined for each individual as described previously.20 Trained
nurses from the UTH provided information about the study and obtained written informed
consent from participants or their guardians. This study was approved by the Institutional
Review Board at the University of Nebraska-Lincoln and the Ethics Committee of the
University of Zambia.
DNA extraction and polymerase chain reaction for KSHV detection
DNA was extracted from buccal swab samples using the Puregene Genomic DNA
Purification Kit (Qiagen) according to manufacturer’s protocol. Extracted DNA was
subjected to polymerase chain reaction (PCR) using primers for human β-actin (Actin1 [5’-
TTCTACAATGAGCTGCGTGT-3’] and Actin2 [5’-GCCAGACAGCACTGTGTTGG-3’])
or GAPDH (GAPDH1 [5’-CCATGGAGAAGGCTGGGG-3’] and GAPDH2 [5’-
CAAAGTTGTCATGGATGACC-3’]). Subsequently, PCR-positive samples were analyzed
by nested PCR for presence of KSHV DNA using previously described primers for the
ORF26 gene.21 Each PCR reaction was performed in a total volume of 25 µl using 0.4 µM
primers and TaKaRa Ex Taq DNA polymerase kit (TaKaRa Biotechnology) according to
manufacturer’s protocol, with the exception of 2.5 units enzyme. For β-actin and GAPDH
reactions, 1 µl genomic DNA was used. For first- and second-round ORF26 PCR, 2 µl
genomic DNA and 2 µl PCR product were used, respectively. All reactions were performed
using the following conditions: 95°C for 5 min, 35 cycles of 95°C for 30 sec, 58°C for 30
sec, 72°C for 30 sec, and one cycle of 72°C for 7 min.
K1 sequencing
Nested primers were used to PCR amplify the K1 gene from KSHV DNA-positive buccal
swab samples: outer primers K1-R2 (5’-AGTACCAATCCACTGGTTGCG-3’) and
K1-1Wh (5’-TGTCTTTCAGACCTTGTTGG-3’); and inner primers K1-F1 (5’-
ATGTTCCTGTATGTTGTCTGC-3’) and K1-4Wh (5’-
TGGTTGCGTATAGTCTTCCG-3’). K1 PCR reaction conditions were similar to those
described above, except the elongation temperature was 68°C. K1 PCR products were gel
purified using the QIAQuick Gel Extraction Kit (Qiagen) according to manufacturer’s
instructions. Purified K1 PCR products were sequenced with primers K1-F1 and OLK1R2
(5’-GCACTGTTTTGTTTGAGTCAC-3’) using the BigDye Terminator v3.1 Cycle
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Sequencing Kit and ABI Prism 3100-Avant DNA Sequencer (Applied Biosystems)
according to manufacturer’s protocols.
Sequence analysis
A 624-nucleotide sequence (positions 100–723) that encompasses VR1 and VR2 of the K1
gene was examined. All sequences were analyzed using BLAST (National Center for
Biotechnology Information) to ensure the amplicon was K1. Subsequently, K1 sequences
from KSHV-infected individuals were aligned to sequences from members of the same
household and inspected for differences using Vector NTI software (v11.0, Invitrogen). A
maximum likelihood tree was constructed for all households using MEGA (v5.04).
Additionally, longitudinal K1 sequences from each individual were aligned and inspected
for differences using Vector NTI software. KSHV genotype of each individual was
determined by K1 sequence alignment to reference strains from GenBank and construction
of a maximum likelihood tree using MEGA (v5.04). K1 reference sequences used for
analysis were AF133038 (A1), AF130305 (A2), U86667 (A3), AF133039 (A4), AF178823
(A5), AF133040 (B), AF133041 (C1), AF133042 (C3), AF133043 (D1), AF133044 (D2),
and AF220292 (E). The K1 sequences generated in this study are available from GenBank
under accession numbers JQ422520 to JQ422550.
Quantitative real-time PCR
Longitudinal samples with K1 sequence data were also analyzed by a duplex quantitative
real-time PCR (qPCR) assay developed to simultaneously quantitate the number of KSHV
genomic copies and cellular equivalents in each sample. All qPCR template samples were
subjected to phenol-chloroform purification, according to standard methods, to ensure
maximum purity for accurate qPCR analysis. Briefly, at least three rounds of phenol-
chloroform and one chloroform purification, followed by ethanol precipitation, were
performed on each DNA sample. qPCR reactions were performed using Taqman chemistry
(Applied Biosystems). Each 25 µl reaction mixture contained the following: 100 ng genomic
DNA template, 300 nM and 200 nM ORF26 forward and reverse nested primers
respectively, 200 nM ORF26 dual-labeled probe RT26p (5’-FAM-
CCATGGTCGTGCCGCACGCA-BHQ1-3’), 30 nM each β-globin primer described
elsewhere,22 200 nM β-globin dual-labeled probe BGX1 (5’-HEX-
CTCCTGAGGAGAAGTCTGCCGTTACTGCC-BHQ1-3’), 1× Taqman buffer, 5 mM
MgCl2, 0.4 mM each dNTP, 0.0125 units Amplitaq Gold, and 0.01 units uracil-DNA
glycosylase (UNG). All reactions were performed with the BioRad iCyclerIQ using the
following conditions: 50°C for 2 min, 95°C for 10 min, and 40 cycles of 95°C for 15 sec,
55°C for 1 min. The standard for KSHV was generated using a sequence of the ORF26 gene
cloned into the pCR2.1 vector (pCR2.1.ORF26) according to the manufacturer’s protocol
(Invitrogen). pCR2.1.ORF26 copy number was calculated based on molecular mass. The β-
globin standard was generated using genomic DNA extracted from the 8E5 cell line and
copy number was calculated by qPCR to a known laboratory standard. The duplex standard
was generated by mixing calculated copy numbers of pCR2.1.ORF26 and 8E5 genomic
DNA in Tris-EDTA, followed by five serial 10-fold dilutions. The cycle threshold values
from PCR amplification of ORF26 and β-globin in the duplex standard were used to
generate a curve for each amplicon. The duplex standard curve was run in parallel with
buccal swab samples for each reaction. KSHV copy number was calculated for each well
and normalized to the β-globin equivalent. All samples were run in triplicate and the mean
KSHV copy number per 10,000 cellular equivalents was calculated.
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RESULTS
KSHV screening and genotype analysis
In the present study, we examined buccal swab samples from individuals (n = 455) of 137
complete households. Among these, 94 individuals from 43 households had KSHV DNA
detectable by PCR in the buccal cavity and we attempted to amplify K1 for sequence
analysis from these samples. Of the 94 KSHV DNA-positive individuals, the K1 gene was
successfully amplified and sequenced in 31 individuals (12 index children and 19 household
members) across 16 households (Fig. 1). A maximum likelihood tree with 11 K1 reference
sequences was generated for KSHV genotype analysis of the 31 K1 sequences (Fig. 2). As
expected, sequences from all 31 individuals clustered with genotypes A5 (n = 17) or B (n =
14), which are the most prevalent KSHV genotypes in Africa.23
KSHV transmission in complete households
Of the 16 households containing individuals in which K1 was sequenced, nine were
examined for intra-household transmission of KSHV to children because K1 sequence data
from the index child and at least one other household member was obtained. Table 1
summarizes demographic information collected from all members of these nine households
(12 index children and 30 household members). Of note, all 12 children had detectable
levels of KSHV antibodies in sera and 11 had detectable KSHV DNA shedding in the buccal
cavity. Twenty-five of the 30 household members were KSHV-seropositive, of which 15
had detectable levels of KSHV DNA in the buccal cavity for at least one time point during
the study. We were then able to obtain K1 sequence from all 11 KSHV DNA-positive index
children and 13 of the 15 household members for at least one time point. Household
members from whom K1 sequences were obtained were mothers and older siblings as
KSHV DNA was not frequently detected in the buccal cavities of other household members.
K1 sequences from the 11 index children and 13 household members of these nine
households were aligned with A5 and B reference sequences and differences represented
phylogenetically (Figs. 3a and 3b). In six households (310, 402, 565, 602, 611, and 638), the
index child had 100% K1 sequence identity to all analyzed household members (Fig. 3a).
Additionally, members from each household clustered to a distinct phylogenetic group with
no overlap between households, providing evidence that cross-contamination between
samples did not occur.
Interestingly, in three other households (163, 488, and 519) the index child had 100% K1
sequence identity to a sibling but not the mother. For household 163, the K1 sequence of the
mother was distinct from her two children, with three amino acid substitutions. For
household 488, the mother’s K1 sequence differed from her children’s by 56 amino acids,
consequently belonging to a different KSHV genotype: A5 versus B (Figs. 3b and 3c). For
the remaining household (519), the two children had identical KSHV K1 sequence, despite
the fact that the only other household member was KSHV-negative as determined by both
antibody and DNA detection (Table 1 and Fig. 3b).
Longitudinal quantification of KSHV in the buccal cavity
To further explore factors that may affect KSHV transmission within the household, we
used qPCR to quantify KSHV burden in 25 of the 31 KSHV genotyped individuals, each of
whom had KSHV-positive buccal swab samples at more than one time point (Fig. 1). Lack
of sufficient quantities of sample or absence of KSHV DNA in previous detection assays
prevented us from quantifying KSHV copy numbers for all time points. Figure 4a illustrates
the KSHV shedding levels in the buccal cavity for each of the 25 individuals analyzed. Of
note, 76% of individuals analyzed had levels of KSHV shedding that varied substantially.
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Furthermore, six individuals had undetectable KSHV shedding for at least one time point,
which was preceded or succeeded by detectable levels of KSHV.
To examine whether HIV-1 infection increases KSHV shedding in the buccal cavity, the
mean number of KSHV copies/104 cells for all time points of each individual was compared
between HIV-1 infected (n = 10) and uninfected (n = 15) individuals (Fig. 4b). Individuals
who were HIV-1 positive had a marginally higher mean and median level of KSHV buccal
shedding compared to uninfected individuals. However, there was no significant difference
(p = 0.57) due to high variation and a small number of samples.
Lack of K1 genetic diversity over time within KSHV-infected individuals
We also sought to determine whether the dominant KSHV genotype in an individual
changes over time, whether these changes correlate with transmission of variant genotypes
within the same household and whether superinfection by other KSHV variants can occur.
For each individual that we obtained K1 sequences from at least two samples over a
minimum of 12 months (n = 18), we inspected sequences for evolution over time. Table 2
summarizes the number of samples analyzed, timespan of samples, and whether K1
sequence varies over time within each individual. Surprisingly, 17 of the 18 individuals had
no variation in the dominant K1 sequence over the period analyzed, even up to 40 months.
Only one individual (163-I01) had detectable K1 sequence variation: a single adenosine/
guanosine mixed nucleotide that resulted in a cysteine/tyrosine mixture at the 100th amino
acid position. However, the sequence variation was only observed at the sixth of seven
follow up time points over the course of a 28-month period. At the subsequent time point,
the variant reverted to the original sequence resulting in no net change in the dominant K1
sequence.
DISCUSSION
The principal objective of the present study was to elucidate the role of household members
as transmission sources for early childhood infection of KSHV in an endemic setting. To
this end, we used molecular analysis of viral sequences to link donor and recipient pairs. Our
analysis of household K1 sequences revealed that in 6 of 9 households the index child had
100% K1 sequence identity to all other household members examined. This suggests that
intra-household transmission is frequent and household practices common to all members
within the household are the means by which KSHV contaminated saliva is transmitted.
Indeed, Butler et al.24 showed that sharing food and/or sauce plates with other household
members is associated with a child being KSHV seropositive. Therefore, if an infected
household member is shedding KSHV in saliva, sharing household food/sauce plates may
provide a route for transmission to all other household members.
Additionally, three households provided evidence of extra-household KSHV transmission.
For two households (488 and 519), we are confident that the index child and sibling did not
acquire KSHV infection from the mother as there was high K1 sequence divergence within
household 488 and no maternal KSHV infection for household 519. For household 163, the
K1 sequences obtained from the children and mother varied by <1.5%. Differences in K1
sequences could be a result of viral evolution in the children as suggested by Mbulaiteye et
al.25 or a minor KSHV variant, undetectable by direct sequencing, may have been
transmitted. Nevertheless, the observation that both children in each household had identical
K1 sequences distinct from their mothers’ suggests that these children did not acquire
KSHV infection from their mothers. Due to dense living conditions within compounds of
Lusaka District, it is likely that these children acquired distinct KSHV variants from
personal contact with community members outside of the household, which were not
analyzed in the present study. Thus, our findings provide molecular evidence to support
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what previous reports have suggested: household members other than the mother, as well as
personal contacts from outside the household may play an important role in KSHV
transmission to children.24, 26, 27
We also report that viral burden in the buccal cavity is highly variable over time (e.g. from
undetectable to high levels, and vice versa) for the majority of household members,
highlighting the importance of longitudinal observation in KSHV transmission studies. This
is consistent with reports in longitudinal cohorts of men who have sex with men in low
infection prevalence settings.28, 29 Within our cohort, adults had periodic and robust lytic
KSHV infection in the buccal cavity, which could increase the opportunity for transmission
to children. Additionally, the high variability of viral shedding may partially explain a lack
and/or inconsistency of correlation between KSHV infection and specific behaviors in which
children are exposed to saliva, making it more difficult to identify the common practices that
may increase the spread of KSHV in endemic areas.
Given the sequence diversity observed within K1, it is unclear whether viral quasispecies
can develop in individuals during the course of KSHV infection. In the present study, we
found that the dominant sequence of K1 in the buccal cavity of an individual did not change
rapidly within the time analyzed. We observed sequence variation in only 1 of 18
individuals, suggesting that K1 evolution can occur within an individual; however, this
variation was not sustained over time. Forward and reverse sequences were of excellent
quality, indicating that the variation detected was genuine. However, it is possible that the
mutation detected was a PCR artifact. In support of our finding that K1 evolution is possible
within an individual, two recent studies have demonstrated that multiple KSHV variants and
even closely related genotypes can exist within the same individual at a given time
point.25, 30 In contrast to our study, these groups sequenced individual K1 clones. This
method is advantageous for detecting minor sequence variants; nevertheless, a small number
of clones can misrepresent the proportion of variants present in the individual. Hence, high
quality direct sequencing of PCR product is ideally suited to determine the dominant
sequences present within a sample. Our findings suggest that although ongoing evolution of
the K1 gene can occur in an individual, the level of variants is minor in the scope of the
individual’s entire viral population and that K1 evolution does not induce a shift in the
dominant viral genotype within an individual over the analyzed time.
One limitation of our study is the small final sample size. In our cohort, we detected KSHV
DNA via PCR in 94 out of 455 individuals. This is not unexpected as not all household
members were KSHV-seropositive. Moreover, a number of previous reports demonstrated
that KSHV DNA is not always detectable in the buccal cavity of KSHV-seropositive
individuals.14, 15, 25 Further limiting the number of households available for analysis, the K1
gene has high sequence variability resulting in PCR detection and sequencing that is not as
sensitive as for the conserved ORF26 gene. Another limitation of our study is the use of
households where children were already KSHV-seropositive, preventing us from directly
correlating levels of household member KSHV shedding in the buccal cavity to the time of
childhood infection.
Despite these limitations, our study is significant as we were able to analyze samples from
complete households in a longitudinal cohort within an endemic area. The cohort analyzed
was representative of urban families in Zambia, and to our knowledge child care practices
do not differ significantly in the rural setting. However, to further substantiate our findings
in other endemic areas, it will be important to correlate KSHV infection in household/
community members with viral transmission to young children in those areas. The findings
of our study are important for developing strategies—such as behavior modification—to
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prevent KSHV transmission during early childhood and therefore reduce KS incidence in
endemic areas.
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Figure 1.
Flowchart summarizing sample analysis from a longitudinal cohort of Zambian households
with at least one KSHV-positive child. Inset boxes indicate number of households
comprised of analyzed individuals. N/A, not applicable.
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Figure 2.
Phylogenetic analysis of K1 amino acid sequence to determine KSHV genotype of each
individual. A maximum likelihood tree was generated with K1 sequences generated in this
study and 11 prototypic reference sequences obtained from GenBank. Sequences generated
in this study are boxed and reference sequences are labeled A1, A2, A3, A4, A5, B, C1, C3,
D1, D2, and E.
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Figure 3.
Alignment of K1 sequences from members of nine households where sequence data was
obtained from the index child and at least one other household member. Maximum
likelihood phylogenetic tree of K1 nucleotide sequence from individuals indicating intra-
household (a) and extra-household (b) transmission of KSHV to children. (c) K1 amino acid
alignment for individuals of households 163 and 488. H02 designates the mother in each
household.
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Figure 4.
Longitudinal quantification of KSHV burden by quantitative real-time PCR analysis of
buccal swab samples. Buccal swab samples were collected from each index child and
mother every four months and from all other household members once a year at UTH in
Lusaka for up to four years. (a) Twenty-five individuals who had KSHV-positive buccal
swab samples by PCR at two or more time points were analyzed. Index children are denoted
with the letter “I”, and household members are denoted with the letter “H”. KSHV burden is
reported as the number of KSHV genomes per 104 cellular genomes with a detection limit of
10 KSHV genomes. (b) Box and scatter plots of mean KSHV burden in buccal swab
samples from 25 HIV-1 negative and positive individuals. Mean (X) and median (―) values
are shown. p = 0.57, two-sided Student’s t-test.
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Table 2
K1 Evolution Over Time
Study ID KSHV
Genotype
Samples Timespan
(Months)
K1 Sequence
Variation
116-H02 B 2 12 −
409-H04 A5 2 12 −
519-I01 B 2 16 −
488-H04 B 2 16 −
310-H02 A5 3 20 −
519-H03 B 3 20 −
201-I01 B 2 24 −
488-I01 B 2 24 −
163-H04 A5 2 24 −
534-H02 A5 3 24 −
602-I01 A5 5 24 −
310-H05 A5 2 28 −
602-H02 A5 4 28 −
163-I01 A5 7 28 +a
638-I01 A5 7 28 −
565-H02 A5 7 32 −
219-H03 B 3 40 −
488-H02 A5 8 40 −
aVariation was not sustained over time.
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